PDC and steatosis: Given the establishment of hepatocyte mitochondrial dysfunction and steatosis during sepsis, we asked whether pharmacological targeting of the hepatic PDK/PDC axis would mitigate the disruption of key metabolic and bioenergetic processes induced by sepsis.